Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.4K
3.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

12.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extending the classical sequence-structure-function paradigm through protein dynamics and context-dependent behavior.

FEBS letters·2026
Same author

King's stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity.

Brain : a journal of neurology·2026
Same author

Comment on: Early Death Among Firefighters: The Need for Further Investigation.

Journal of occupational and environmental medicine·2026
Same author

Brief comments on "Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis".

Journal of pharmaceutical analysis·2026
Same author

Gastrocnemius recession in the treatment of isolated metatarsalgia: A systematic review of surgical outcomes and complications.

Journal of orthopaedic surgery (Hong Kong)·2026
Same author

Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol.

Frontiers in public health·2025
Same journal

[Italian Cystic Fibrosis Registry (ICFR). Report 2023-2024].

Epidemiologia e prevenzione·2026
Same journal

[Multicenter experience of the Lombardy Health Protection Agencies (ATS) in the application of an algorithm to estimate disability prevalence and profiles based on routine administrative data: from data sharing to regional-level analysis].

Epidemiologia e prevenzione·2026
Same journal

[Errata corrige Errata corrige Epidemiol Prev 2026;50(1):37-47].

Epidemiologia e prevenzione·2026
Same journal

[Changes in agri-food production systems and nutritional profile of foods (1930-2024)].

Epidemiologia e prevenzione·2026
Same journal

["Tell me a story": the use of storytelling for the prevention of workplace injuries].

Epidemiologia e prevenzione·2026
Same journal

[A gravity model approach to the network of Centres for Assistance and Urgency and Emergency Department in Emilia-Romagna (Northern Italy): a tool to support equitable access planning].

Epidemiologia e prevenzione·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

[Oncogenesis: only somatic mutations?]

Enrico Oddone1, Carlo Modonesi2, Alessandro Giuliani3

  • 1Dipartimento di sanità pubblica, medicina sperimentale e forense, Università degli Studi di Pavia. enrico.oddone@unipv.it.

Epidemiologia E Prevenzione
|September 26, 2015
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Related Experiment Videos

Last Updated: Apr 3, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K